Raphael Pharmaceutical (RAPH) Debt Ratio (2020 - 2025)

Raphael Pharmaceutical has disclosed Debt Ratio across 5 years of filings, most recently posting 0.64 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.64, down 57.75% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.64 (down 57.75% YoY), and the FY2025 annual result was 0.64, down 57.75% from the prior year.
• Debt Ratio came in at 0.64 for Q4 2025 at Raphael Pharmaceutical, down from 5.86 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 5.86 in Q3 2025 to a low of 0.01 in Q1 2022.
• The 4-year median for Debt Ratio is 0.44 (2025), against an average of 1.11.
• Across the five-year window, Debt Ratio surged 87.1% in 2021 and plunged 82.72% in 2022, its largest moves.
• Raphael Pharmaceutical's Debt Ratio stood at 0.05 in 2021, then slumped by 82.72% to 0.01 in 2022, then soared by 16755.56% to 1.52 in 2024, then slumped by 57.75% to 0.64 in 2025.
• The last three Debt Ratio figures came in at 0.64 (Q4 2025), 5.86 (Q3 2025), and 1.37 (Q2 2025), per Business Quant data.